Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Korea tightens clinical trials control:

This article was originally published in Clinica

Executive Summary

All clinical trials in Korea, large or small, will need the prior approval of the Korean FDA, as of February 14 2002, when the revised pharmaceutical affairs law takes effect, reports Pharma Koreana. This aspect of the law amendment, decided on August 14 2001, is designed to provide better patient protection.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT073871

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel